A recent Medscape article discussed a new first in the world of vaccines. Last week, the FDA approved the first-ever vaccine against Ebola. The drug, Ervebo from Merck & Co, is a single-dose injection that was used by the World Health Organization to combat the world’s second-largest Ebola outbreak in the DRC in 2018. It is meant for individuals 18 and older, and is a live attenuated vaccine that was genetically engineered to contain a protein from the deadly Zaire ebolavirus.
Quick Hits: FDA Approves First Ebola Vaccine
Last week, the FDA approved Ervebo, the first-ever Ebola vaccine that was developed during a two-year outbreak in Guinea.
Dec 23, 2019
Recommended
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
